Meeting
Abstract Number: A8
SHM Converge 2022
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is defined as the presence of ≥5% of hepatic steatosis (HS) in the absence of other liver disorders, such as chronic viral or autoimmune hepatitis, steatosis induced by drugs, significant alcohol consumption, hemochromatosis, or Wilson’s disease. There is limited literature describing national prevalence and epidemiological characteristics of NAFLD in […]
Abstract Number: 385
SHM Converge 2021
Case Presentation: Mr. O is a 28 year old Navy cadet with no significant past medical history who presented to the Emergency Department with three days of malaise, nausea, polyuria, and polydipsia in the setting of recent steroids for a new rash. On presentation, Mr. O’s glucose returned at 624 mg/dL, pH was 7.28 and […]